The study is the latest evidence to suggest that widely popular diabetes and weight-loss shots may have a role in cancer prevention.
may lower patients’ risk of developing some common types of cancer that are closely linked to obesity, new evidence suggests.
Novo’s American depositary receipts rose 2.2% at 11:40 a.m. in New York on Friday. Eli Lilly’s shares gained 1.6%.The study is based on electronic health records for more than 1.6 million patients with Type 2 diabetes for 15 years ending in November 2018. Since that was less than a year after Ozempic was introduced in the U.S.
“Obesity is the tobacco of our age when it comes to cancer risk,” said Arif Kamal, chief patient officer of the American Cancer Society. Kamal said the early evidence on GLP-1s is “compelling.” “This is very significant because usually when you get these cancers, you have a poor prognosis,” said Wang. She conducted the research under the guidance of Case Western Professor Nathan Berger, who died last month at the age of 83.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Diabetes drugs like Ozempic lower cancer risks: StudyA class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday.
Read more »
Biden calls for lower prices of Ozempic, similar drugsUS President Joe Biden on Tuesday called on pharmaceutical giants Novo Nordisk and Eli Lilly to lower prices for diabetes and weight loss drugs such as Ozempic, saying firms must stop 'ripping off the American people.'
Read more »
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court.
Read more »
Wegovy and Ozempic linked to reduced incidence and recurrence of alcohol abuse or dependence, study suggestsResearchers investigated the potential therapeutic benefits of semaglutide for alcohol use disorders.
Read more »
Weight-loss jabs including Ozempic and Wegovy linked to rare condition that causes blindnessPeople using semaglutide to treat diabetes or lose weight may be at higher risk of developing a condition that causes sudden sight loss, according to a new study.
Read more »
‘Skinny jabs’ like Ozempic and Wegovy could trigger terrifying eye condition and leave you BLIND...Sun Health Explainer: Fat jabs
Read more »